Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Cash from Financing Activities (2018 - 2025)

TELA Bio has reported Cash from Financing Activities over the past 8 years, most recently at $25.8 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $25.8 million for Q4 2025, down 39.77% from a year ago — trailing twelve months through Dec 2025 was $25.8 million (down 40.2% YoY), and the annual figure for FY2025 was $25.8 million, down 40.2%.
  • Cash from Financing Activities for Q4 2025 was $25.8 million at TELA Bio, up from $24000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for TELA hit a ceiling of $46.4 million in Q2 2023 and a floor of -$235000.0 in Q1 2023.
  • Median Cash from Financing Activities over the past 5 years was $63500.0 (2023), compared with a mean of $7.8 million.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 505.56% in 2022 and later skyrocketed 194936.36% in 2024.
  • TELA Bio's Cash from Financing Activities stood at $174000.0 in 2021, then crashed by 225.86% to -$219000.0 in 2022, then soared by 110.05% to $22000.0 in 2023, then skyrocketed by 194936.36% to $42.9 million in 2024, then plummeted by 39.77% to $25.8 million in 2025.
  • The last three reported values for Cash from Financing Activities were $25.8 million (Q4 2025), $24000.0 (Q3 2025), and -$3000.0 (Q2 2025) per Business Quant data.